MARIA SONIA
GAZTAMBIDE SAENZ
Ikertzaileren 2004-2022 tartean
![Foto de MARIA SONIA](/img/nophoto.png)
![Foto de Novartis (Sweden)](/img/noimage_org.png)
Novartis (Sweden)
Täby, SueciaNovartis (Sweden)-ko ikertzaileekin lankidetzan egindako argitalpenak (2)
2010
-
Effect of nateglinide on the incidence of diabetes and cardiovascular events
New England Journal of Medicine, Vol. 362, Núm. 16, pp. 1463-1476
-
Effect of valsartan on the incidence of diabetes and cardiovascular events
New England Journal of Medicine, Vol. 362, Núm. 16, pp. 1477-1490